Accountability for Cancer Care Through Undoing Racism and Equity (ACCURE)
Breast Cancer, Lung Cancer
About this trial
This is an interventional health services research trial for Breast Cancer focused on measuring breast cancer, lung cancer, cancer treatments, racial inequity, health systems change, transparency, accountability
Eligibility Criteria
Inclusion Criteria:
- White or African American patients aged 18 or older
- Recently received a first diagnosis of stage 1 or 2 breast or lung cancer
- Patient plans to initiate oncology treatment with curative intent
Exclusion Criteria:
- Have cognitive impairments or limited English proficiency that would preclude their ability to comprehend survey questions
Sites / Locations
- Cone Health, Regional Cancer Center
- University of Pittsburgh Medical Center, Hillman Comprehensive Cancer Center
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ACCURE Navigator
Usual Care by Cancer Center Care Team
For those patients assigned to the ACCURE Navigator, the ACCURE Real-Time Registry is programmed to automatically alert the Navigator when a patient misses a scheduled treatment appointment and to require the Navigator to include details as to how she addressed and resolved that missed appointment, ensuring the ACCURE Navigator's proactive approach to addressing such issues. In addition, a warning message will be produced if no follow-up appointments or procedures are scheduled within 21 days of the index visit.
A list of registry warnings about all patients enrolled in the study will be delivered securely to a designated representative at the clinic.